Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rec 0/0438 in Neurogenic Detrusor Overactivity
NCT03482037Phase 2Completed
- Sponsor
- Recordati SpA
- Start
- Jun 2018
- Primary completion
- Mar 2019
- Countries
- 4
01
Overview
A Phase 2 trial of rec 0438 in neurogenic detrusor overactivity (NDO), sponsored by Recordati SpA. Started Jun 2018; status: completed.
02
Drugs
rec 0438
03
Conditions
neurogenic detrusor overactivity (NDO)
Beyond the preview
Go deeper on NCT03482037.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03482037.